BIDMC-led Trial Leads to FDA approval of Coronary Drug-coated Balloons
DAIC
MARCH 13, 2024
Smith Center for Outcomes Research in Cardiology and section chief of Interventional Cardiology at BIDMC. Even with advances in stent technology, patients with coronary in-stent restenosis continue to comprise approximately 10 percent of individuals undergoing angioplasty interventions each year. and Susan F.
116 
Let's personalize your content